Summary.
Overexpression of chromosome 21 genes is directly or indirectly responsible for the Down syndrome phenotype. In order to analyse chromosome 21 gene products (Chr21Ps), we extracted proteins from fetal human brain cortex and applied an ultracentrifugal and chromatographic prefractionation principle followed by two-dimensional gel electrophoresis (2-DE) and mass-spectrometrical analysis using high-throughput automated MALDI-TOF/TOF. Nine Chr21Ps were identified: pyridoxal kinase; superoxide dismutase [Cu/Zn] 1; carbonyl reductase 1; ES1 protein homolog, mitochondrial [Precursor]; cystathionine-beta-synthetase; T-complex protein 1, theta subunit; cystatin B; 6-phosphofructokinase; glycinamide ribonucleotide synthetase. Mass-spectrometric characterisation of Chr21Ps following separation in 2-DE gels is a useful tool for the analysis of these structures in brain, independent of antibody availability and specificity.
Similar content being viewed by others
References
K Amano H Sago C Uchikawa T Suzuki SE Kotliarova N Nukina CJ Epstein K Yamakawa (2004) ArticleTitleDosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome Hum Mol Genet 13 1333–1340 Occurrence Handle15138197 Occurrence Handle1:CAS:528:DC%2BD2cXkvVSrsLk%3D Occurrence Handle10.1093/hmg/ddh154
MM Bradford (1976) ArticleTitleA rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 248–254 Occurrence Handle942051 Occurrence Handle1:CAS:528:DyaE28XksVehtrY%3D Occurrence Handle10.1016/0003-2697(76)90527-3
K Brannvall H Hjelm L Korhonen U Lahtinen AE Lehesjoki D Lindholm (2003) ArticleTitleCystatin-B is expressed by neural stem cells and by differentiated neurons and astrocytes Biochem Biophys Res Commun 308 369–374 Occurrence Handle12901878 Occurrence Handle1:CAS:528:DC%2BD3sXlvFGhu7Y%3D Occurrence Handle10.1016/S0006-291X(03)01386-X
G Brodsky T Barnes J Bleskan L Becker M Cox D Patterson (1997) ArticleTitleThe human GARS-AIRS-GART gene encodes two proteins which are differentially expressed during human brain development and temporally overexpressed in cerebellum of individuals with Down syndrome Hum Mol Genet 6 2043–2050 Occurrence Handle9328467 Occurrence Handle1:CAS:528:DyaK2sXntFWrt7w%3D Occurrence Handle10.1093/hmg/6.12.2043
MS Cheon SH Kim ML Yaspo F Blasi Y Aoki K Melen G Lubec (2003a) ArticleTitleProtein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part I) Amino Acids 24 111–117 Occurrence Handle1:CAS:528:DC%2BD3sXhslGjsrk%3D
MS Cheon M Bajo SH Kim JO Claudio AK Stewart D Patterson WD Kruger H Kondoh G Lubec (2003b) ArticleTitleProtein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part II) Amino Acids 24 119–125 Occurrence Handle1:CAS:528:DC%2BD3sXhslGjsrY%3D
MS Cheon SH Kim V Ovod N Kopitar Jerala JI Morgan Y Hatefi T Ijuin T Takenawa G Lubec (2003c) ArticleTitleProtein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part III) Amino Acids 24 127–134 Occurrence Handle1:CAS:528:DC%2BD3sXhslGjsrc%3D
MS Cheon KS Shim SH Kim A Hara G Lubec (2003d) ArticleTitleProtein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part IV) Amino Acids 25 41–47 Occurrence Handle1:CAS:528:DC%2BD3sXkvFymsr8%3D
JB de Haan B Susil M Pritchard I Kola (2003) ArticleTitleAn altered antioxidant balance occurs in Down syndrome fetal organs: implications for the “gene dosage effect” hypothesis J Neural Transm Suppl 67 67–83 Occurrence Handle15068240 Occurrence Handle1:CAS:528:DC%2BD2cXjsFyrsbk%3D
R Eldridge M Iivanainen R Stern T Koerber BJ Wilder (1983) ArticleTitle‘Baltic’ myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin Lancet 2 838–842 Occurrence Handle6137660 Occurrence Handle1:STN:280:DyaL2c%2Fht1yrtA%3D%3D Occurrence Handle10.1016/S0140-6736(83)90749-3
A Elson D Levanon Y Weiss Y Groner (1994) ArticleTitleOverexpression of liver-type phosphofructokinase (PFKL) in transgenic-PFKL mice: implication for gene dosage in trisomy 21 Biochem J 299 409–415 Occurrence Handle8172601 Occurrence Handle1:CAS:528:DyaK2cXisVWrt7c%3D
E Engidawork N Baiic M Fountoulakis M Dierssen S Greber-Platzer G Lubec (2001) ArticleTitleBeta-amyloid precursor protein, ETS-2 and collagen alpha 1 (VI) chain precursor, encoded on chromosome 21, are not overexpressed in fetal Down syndrome: further evidence against gene dosage effect J Neural Transm Suppl 61 335–346 Occurrence Handle11771756
E Engidawork G Lubec (2001) ArticleTitleProtein expression in Down syndrome brain Amino Acids 21 331–361 Occurrence Handle11858695 Occurrence Handle1:CAS:528:DC%2BD38XitVWitbY%3D Occurrence Handle10.1007/s007260170001
E Engidawork G Lubec (2003) ArticleTitleMolecular changes in fetal Down syndrome brain J Neurochem 84 895–904 Occurrence Handle12603815 Occurrence Handle1:CAS:528:DC%2BD3sXit1ejtrk%3D Occurrence Handle10.1046/j.1471-4159.2003.01614.x
CJ Epstein (1995) Down syndrome CR Scriver AL Beaudet WS Sly D Valle (Eds) The metabolic and molecular bases of inherited disease EditionNumber7 NumberInSeriesI McGraw-Hill New York 749–794
R Ferrando-Miguel MS Cheon G Lubec (2004) ArticleTitleProtein levels of genes encoded on chromosome 21 in fetal Down Syndrome brain (Part V): overexpression of phosphatidyl-inositol-glycan class P protein (DSCR5) Amino Acids 26 255–261 Occurrence Handle15221505 Occurrence Handle1:CAS:528:DC%2BD2cXkvF2ms7c%3D Occurrence Handle10.1007/s00726-004-0065-9
R Ferrando-Miguel MS Cheon JW Yang G Lubec (2003) ArticleTitleOverexpression of transcription factor BACH1 in fetal Down syndrome brain J Neural Transm Suppl 67 193–205 Occurrence Handle15068251 Occurrence Handle1:CAS:528:DC%2BD2cXjsFyrtrk%3D
M Fountoulakis (2001) ArticleTitleProteomics: current technologies and applications in neurological disorders and toxicology Amino Acids 21 363–381 Occurrence Handle11858696 Occurrence Handle1:CAS:528:DC%2BD38XitVWitbc%3D Occurrence Handle10.1007/s007260170002
M Fountoulakis JF Juranville M Dierssen G Lubec (2002) ArticleTitleProteomic analysis of the fetal brain Proteomics 2 1547–1576 Occurrence Handle12442255 Occurrence Handle1:CAS:528:DC%2BD38XpsVOmsr4%3D Occurrence Handle10.1002/1615-9861(200211)2:11<1547::AID-PROT1547>3.0.CO;2-M
JJ Fuentes L Genesca TJ Kingsbury KW Cunningham M Perez-Riva X Estivill S de la Luna (2000) ArticleTitleDSCR1, over-expressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways Hum Mol Genet 9 1681–1690 Occurrence Handle10861295 Occurrence Handle1:CAS:528:DC%2BD3cXkvFCkur0%3D Occurrence Handle10.1093/hmg/9.11.1681
Y Gitton N Dahmane S Baik A Ruiz i Altaba L Neidhardt M Scholze BG Herrmann P Kahlem A Benkahla S Schrinner R Yildirimman R Herwig H Lehrach ML Yaspo InstitutionalAuthorNameHSA21 expression map initiative (2002) ArticleTitleA gene expression map of human chromosome 21 orthologues in the mouse Nature 420 586–590 Occurrence Handle12466855 Occurrence Handle1:CAS:528:DC%2BD38Xpt1WhsLs%3D Occurrence Handle10.1038/nature01270
T Gulesserian E Engidawork M Fountoulakis G Lubec (2001) ArticleTitleAntioxidant proteins in fetal brain: superoxide dismutase-1 (SOD-1) protein is not overexpressed in fetal Down syndrome J Neural Transm Suppl 61 71–84 Occurrence Handle11771762
M Hattori A Fujiyama TD Taylor H Watanabe T Yada HS Park A Toyoda K Ishii Y Totoki DK Choi Y Groner E Soeda M Ohki T Takagi Y Sakaki S Taudien K Blechschmidt A Polley U Menzel J Delabar K Kumpf R Lehmann D Patterson K Reichwald A Rump M Schillhabel A Schudy W Zimmermann A Rosenthal J Kudoh K Schibuya K Kawasaki S Asakawa A Shintani T Sasaki K Nagamine S Mitsuyama SE Antonarakis S Minoshima N Shimizu G Nordsiek K Hornischer P Brant M Scharfe O Schon A Desario J Reichelt G Kauer H Blocker J Ramser A Beck S Klages S Hennig L Riesselmann E Dagand T Haaf S Wehrmeyer K Borzym K Gardiner D Nizetic F Francis H Lehrach R Reinhardt ML Yaspo InstitutionalAuthorNameChromosome 21 mapping and sequencing consortium (2000) ArticleTitleThe DNA sequence of human chromosome 21 Nature 405 311–319 Occurrence Handle10830953 Occurrence Handle1:CAS:528:DC%2BD3cXjs1KlsL8%3D Occurrence Handle10.1038/35012518
M Jarvinen A Rinne (1982) ArticleTitleHuman spleen cysteineproteinase inhibitor: purification, fractionation into isoelectric variants and some properties of the variants Biochim Biophys Acta 708 210–217 Occurrence Handle6184075 Occurrence Handle1:CAS:528:DyaL3sXitFaq
P Kahlem M Sultan R Herwig M Steinfath D Balzereit B Eppens NG Saran MT Pletcher ST South G Stetten H Lehrach RH Reeves ML Yaspo (2004) ArticleTitleTranscript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome Genome Res 14 1258–1267 Occurrence Handle15231742 Occurrence Handle1:CAS:528:DC%2BD2cXlvFWjsbY%3D Occurrence Handle10.1101/gr.1951304
K Karlsson N Cairns G Lubec M Fountoulakis (1999) ArticleTitleEnrichment of human brain proteins by heparin chromatography Electrophoresis 20 2970–2976 Occurrence Handle10546835 Occurrence Handle1:CAS:528:DyaK1MXmvFahtrY%3D Occurrence Handle10.1002/(SICI)1522-2683(19991001)20:14<2970::AID-ELPS2970>3.0.CO;2-P
PJ Kingham JM Pocock (2001) ArticleTitleMicroglial secreted cathepsin B induces neuronal apoptosis J Neurochem 76 1475–1484 Occurrence Handle11238732 Occurrence Handle1:CAS:528:DC%2BD3MXhvVCjur0%3D Occurrence Handle10.1046/j.1471-4159.2001.00146.x
M Koskiniemi M Donner H Majuri M Haltia R Norio (1974) ArticleTitleProgressive myoclonus epilepsy. A clinical and histopathological study Acta Neurol Scand 50 307–332 Occurrence Handle4835645 Occurrence Handle1:STN:280:DyaE2c3ltFGntg%3D%3D Occurrence Handle10.1111/j.1600-0404.1974.tb02782.x
K Krapfenbauer M Fountoulakis G Lubec (2003) ArticleTitleA rat brain protein expression map including cytosolic and enriched mitochondrial and microsomal fractions Electrophoresis 24 1847–1870 Occurrence Handle12783461 Occurrence Handle1:CAS:528:DC%2BD3sXltVenuro%3D Occurrence Handle10.1002/elps.200305401
CA Lemere JS Munger GP Shi L Natkin C Haass HA Chapman DJ Selkoe (1995) ArticleTitleThe lysosomal cysteine protease, cathepsin S, is increased in Alzheimer’s disease and Down syndrome brain. An immunocytochemical study Am J Pathol 146 848–860 Occurrence Handle7717452 Occurrence Handle1:STN:280:DyaK2M3jtlCqsQ%3D%3D
P Lescuyer DF Hochstrasser JC Sanchez (2004) ArticleTitleComprehensive proteome analysis by chromatographic protein prefractionation Electrophoresis 25 1125–1135 Occurrence Handle15095456 Occurrence Handle1:CAS:528:DC%2BD2cXjvVart7c%3D Occurrence Handle10.1002/elps.200305792
G Lubec M Bajo MS Cheon H Bajova LH Matherly (2003) ArticleTitleIncreased expression of human reduced folate carrier in fetal Down syndrome brain J Neural Transm Suppl 67 95–103 Occurrence Handle15068242 Occurrence Handle1:CAS:528:DC%2BD2cXjsFyrsbc%3D
G Lubec E Engidawork (2002) ArticleTitleThe brain in Down syndrome (TRISOMY 21) J Neurol 249 1347–1356 Occurrence Handle12382149 Occurrence Handle1:CAS:528:DC%2BD38XovFGrtbs%3D Occurrence Handle10.1007/s00415-002-0799-9
G Lubec K Krapfenbauer M Fountoulakis (2003) ArticleTitleProteomics in brain research: potentials and limitations Prog Neurobiol 69 193–211 Occurrence Handle12758110 Occurrence Handle1:CAS:528:DC%2BD3sXjvFWnsbc%3D Occurrence Handle10.1016/S0301-0082(03)00036-4
M Mann RC Hendrickson A Pandey (2001) ArticleTitleAnalysis of proteins and proteomes by mass spectrometry Annu Rev Biochem 70 437–473 Occurrence Handle11395414 Occurrence Handle1:CAS:528:DC%2BD3MXlsVehtL4%3D Occurrence Handle10.1146/annurev.biochem.70.1.437
RF Miguel A Pollak G Lubec (2005) ArticleTitleMetalloproteinase ADAMTS-1 but not ADAMTS-5 is manifold overexpressed in neurodegenerative disorders as Down syndrome, Alzheimer’s and Pick’s disease Brain Res Mol Brain Res 133 1–5 Occurrence Handle15661359 Occurrence Handle1:CAS:528:DC%2BD2MXms1yhtw%3D%3D Occurrence Handle10.1016/j.molbrainres.2004.09.008
R Norio M Koskiniemi (1979) ArticleTitleProgressive myoclonus epilepsy: genetic and nosological aspects with special reference to 107 Finnish patients Clin Genet 15 382–398 Occurrence Handle109240 Occurrence Handle1:STN:280:DyaE1M7ptVamsg%3D%3D Occurrence Handle10.1111/j.1399-0004.1979.tb01770.x
M Peled-Kamar H Degani P Bendel R Margalit Y Groner (1998) ArticleTitleAltered brain glucose metabolism in transgenic-PFKL mice with elevated L-phosphofructokinase: in vivo NMR studies Brain Res 810 138–145 Occurrence Handle9813288 Occurrence Handle1:CAS:528:DyaK1cXntVyitbs%3D Occurrence Handle10.1016/S0006-8993(98)00899-3
C Pucharcos JJ Fuentes C Casas S de la Luna S Alcantara ML Arbones E Soriano X Estivill M Pritchard (1999) ArticleTitleAlu-splice cloning of human intersectin (ITSN), a putative multivalent binding protein expressed in proliferating and differentiating neurons and over-expressed in Down syndrome Eur J Hum Genet 7 704–712 Occurrence Handle10482960 Occurrence Handle1:CAS:528:DyaK1MXmvVGlsr0%3D Occurrence Handle10.1038/sj.ejhg.5200356
A Reymond V Marigo MB Yaylaoglu A Leoni C Ucla N Scamuffa C Caccioppoli ET Dermitzakis R Lyle S Banfi G Eichele SE Antonarakis A Ballabio (2002) ArticleTitleHuman chromosome 21 gene expression atlas in the mouse Nature 420 582–586 Occurrence Handle12466854 Occurrence Handle1:CAS:528:DC%2BD38Xpt1Whs7o%3D Occurrence Handle10.1038/nature01178
PG Righetti A Castagna B Herbert F Reymond JS Rossier (2003) ArticleTitlePrefractionation techniques in proteome analysis Proteomics 3 1397–1407 Occurrence Handle12923764 Occurrence Handle1:CAS:528:DC%2BD3sXmvFOqs7k%3D Occurrence Handle10.1002/pmic.200300472
A Ritonja W Machleidt AJ Barrett (1985) ArticleTitleAmino acid sequence of the intracellular cysteine proteinase inhibitor cystatin B from human liver Biochem Biophys Res Commun 131 1187–1192 Occurrence Handle3902020 Occurrence Handle1:CAS:528:DyaL2MXmtV2lur0%3D Occurrence Handle10.1016/0006-291X(85)90216-5
KS Shim R Ferrando-Miguel G Lubec (2003) ArticleTitleAberrant protein expression of transcription factors BACH1 and ERG, both encoded on chromosome 21, in brains of patients with Down syndrome and Alzheimer’s disease J Neural Transm Suppl 67 39–49 Occurrence Handle15068237 Occurrence Handle1:CAS:528:DC%2BD2cXjsFyrsbo%3D
J-H Shin R Weitzdörfer M Fountoulakis G Lubec (2004) ArticleTitleExpression of cystathionine beta-synthase, pyridoxal kinase, and ES1 protein homolog (mitochondrial precursor) in fetal Down syndrome brain Neurochem Int 45 73–79 Occurrence Handle15082224 Occurrence Handle1:CAS:528:DC%2BD2cXjtVCit7g%3D Occurrence Handle10.1016/j.neuint.2003.12.004
J-H Shin K Krapfenbauer G Lubec (2005) ArticleTitleColumn chromatographic prefractionation leads to the detection of 543 different gene products in human fetal brain Electrophoresis 26 2759–2778 Occurrence Handle15966016 Occurrence Handle1:CAS:528:DC%2BD2MXotFamsr0%3D Occurrence Handle10.1002/elps.200500051
V Turk W Bode (1991) ArticleTitleThe cystatins: protein inhibitors of cysteine proteinases FEBS Lett 285 213–219 Occurrence Handle1855589 Occurrence Handle1:CAS:528:DyaK3MXltV2jsr8%3D Occurrence Handle10.1016/0014-5793(91)80804-C
R Vitorino MJ Lobo AJ Ferrer-Correira JR Dubin KB Tomer PM Domingues FM Amado (2004) ArticleTitleIdentification of human whole saliva protein components using proteomics Proteomics 4 1109–1115 Occurrence Handle15048992 Occurrence Handle1:CAS:528:DC%2BD2cXjt1SmtLg%3D Occurrence Handle10.1002/pmic.200300638
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shin, JH., Krapfenbauer, K. & Lubec, G. Mass-spectrometrical analysis of proteins encoded on chromosome 21 in human fetal brain. Amino Acids 31, 435–447 (2006). https://doi.org/10.1007/s00726-005-0257-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-005-0257-y